Evidence map›Paper›PMID 29164332›Full record

ArticleEuropean archives of psychiatry and clinical neuroscience2018

Individual trajectories of cognitive performance in first episode psychosis: a 2-year follow-up study.

A M Sánchez-Torres, L Moreno-Izco, R Lorente-Omeñaca, B Cabrera, A Lobo, A M González-Pinto, J Merchán-Naranjo, I Corripio, E Vieta, E de la Serna and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of psychiatry and clinical neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Article
  3. Elevated Extracellular Free Water in the Brain Predicts Clinical Improvement in First-Episode Psychosis.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

A M Sánchez-TorresDepartment of Psychiatry, Complejo Hospitalario de Navarra, c/Irunlarrea 3, 31008, Pamplona, Spain.
L Moreno-IzcoDepartment of Psychiatry, Complejo Hospitalario de Navarra, c/Irunlarrea 3, 31008, Pamplona, Spain.
R Lorente-OmeñacaDepartment of Psychiatry, Complejo Hospitalario de Navarra, c/Irunlarrea 3, 31008, Pamplona, Spain.
B CabreraBarcelona Clínic Schizophrenia Unit, Hospital Clínic de Barcelona, Barcelona, Spain.
A LoboDepartment of Medicine and Psychiatry, Aragon Institute for Health Research (IIS Aragon), University of Zaragoza, Saragossa, Spain.
A M González-PintoNetwork Centre for Biomedical Research in Mental Health (CIBERSAM), Madrid, Spain.
J Merchán-NaranjoNetwork Centre for Biomedical Research in Mental Health (CIBERSAM), Madrid, Spain.
I CorripioNetwork Centre for Biomedical Research in Mental Health (CIBERSAM), Madrid, Spain.
E VietaNetwork Centre for Biomedical Research in Mental Health (CIBERSAM), Madrid, Spain.
E de la SernaNetwork Centre for Biomedical Research in Mental Health (CIBERSAM), Madrid, Spain.
A ButjosaNetwork Centre for Biomedical Research in Mental Health (CIBERSAM), Madrid, Spain.
F ContrerasNetwork Centre for Biomedical Research in Mental Health (CIBERSAM), Madrid, Spain.
S SarróNetwork Centre for Biomedical Research in Mental Health (CIBERSAM), Madrid, Spain.
G MezquidaBarcelona Clínic Schizophrenia Unit, Hospital Clínic de Barcelona, Barcelona, Spain.
M RibeiroDepartment of Psychiatry, Complejo Hospitalario de Navarra, c/Irunlarrea 3, 31008, Pamplona, Spain.
M BernardoBarcelona Clínic Schizophrenia Unit, Hospital Clínic de Barcelona, Barcelona, Spain.
M J CuestaDepartment of Psychiatry, Complejo Hospitalario de Navarra, c/Irunlarrea 3, 31008, Pamplona, Spain. mcuestaz@cfnavarra.es.
PEPs group

Funding

Departamento de Salud, Gobierno de Navarra 87/2014Instituto de Salud Carlos III 08/1026Instituto de Salud Carlos III 11/02831Instituto de Salud Carlos III 14/01621
6 · The paper itself

Abstract

Individual changes over time in cognition in patients with psychotic disorders have been studied very little, especially in the case of first episode psychosis (FEP). We aimed to establish whether change in individual trajectories in cognition over 2 years of a sample of 159 FEP patients was reliable and clinically significant, using the reliable change index (RCI) and clinically significant change (CSC) methods. We also studied a sample of 151 matched healthy controls. Patients and controls were assessed with a set of neuropsychological tests, as well as premorbid, clinical and functionality measures. We analysed the course of cognitive measures over time, using analysis of variance, and the individual trajectories in the cognitive measures with the regression-based RCI (RCI

Indexed as

Disease ProgressionAdolescentAdultAttentionCognitive DysfunctionExecutive FunctionFemaleFollow-Up StudiesHumansMaleNeuropsychological TestsPsychotic DisordersYoung AdultClinically significant changeCognitionFirst episode psychosisLongitudinalReliable change indexSchizophrenia

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.